June 2017

In this panel discussion, panelists addressed critical decisions related to technology and talent that can either create or destroy M&A value in the due-diligence and integration phases.

In today’s digital economy, technology and talent drive business performance. That’s why these two dimensions are so critical to maximizing the return on any M&A transaction.

During the web panel discussion, James O’Gara, CEO and Founder of OnMessage, moderates an engaging discussion between John Hotta, Senior Advisor at Capital Expert Services, and Aaron Belcher, Founder of APB Law.

The webinar discussion focused around the following critical business decisions:

  • Choosing the due diligence and integration dream team
  • Cyber-security considerations
  • IP ownership decisions
  • Manager to employee communication
  • Cultural integration
  • Plus more

Request a Recording
of the web panel discussion




ShareVault’s secure document sharing solution gives pharmaceutical and biotechnology  organizations the confidence to simply and securely share sensitive documents with third parties during due diligence, product development, technology transfers, fundraising, partnering, collaborative research and other activities that require the highest level of document security.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.